Iron and infection in the tropics: paediatric clinical correlates

S J Oppenheimer1

  • 1Liverpool School of Tropical Medicine, UK. stephen.oppenheimer@paediatrics.oxford.ac.uk

Insights

Iron supplementation in children can worsen infections like malaria, especially when immunity is low. Careful dosing and timing are crucial for safe iron therapy and food fortification programs.

Area of Science:

  • Public Health
  • Nutritional Immunology
  • Pediatric Infectious Diseases

Background:

  • Iron deficiency is a global child health issue, addressed by supplementation and fortification.
  • The interplay between iron and infection necessitates clear guidelines for iron interventions.
  • Iron overload can increase susceptibility to infections, with varied mechanisms.

Purpose of the Study:

  • To review the complex relationship between iron therapy and infection risk in children.
  • To highlight the need for evidence-based guidelines for iron supplementation and food fortification.
  • To discuss the impact of iron interventions on specific infections like malaria and respiratory diseases.

Main Methods:

  • Literature review of studies on iron supplementation, food fortification, and iron chelation.
  • Analysis of clinical trial data and observational studies concerning iron and infection.
  • Examination of factors influencing iron-infection interactions, including immunity and endemic diseases.

Main Results:

  • Parenteral iron in Papua New Guinea linked to increased malaria and respiratory illness in infants.
  • Oral iron in African studies showed adverse effects, particularly in immunocompromised children with therapeutic doses.
  • Iron chelation therapy demonstrated protection against malaria but potential risk for fungal and Yersinia infections.

Conclusions:

  • Iron interventions require careful consideration of endemic disease prevalence, host immunity, and age.
  • Optimizing the timing and dosage of oral iron is essential for safe and effective recommendations.
  • Balancing iron supplementation benefits against infection risks is critical for public health programs.

Related Concept Videos

Infection01:20

Infection

When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...